please save me the trolling. What are you smoking AGN took 3...

First 53 Last

Share
Profile

Follow
Roch2077

10,005 Posts.

1965

10/05/24

06:30

Post #: 73753754
Share

Originally posted by Hawk70: ↑

then explain to me when they check for side effects and that the drug is targeting and functioning correctly in phase 1 study is not human trials?

They don't check if the drug is 'targeting or functioning' in a stage 1 trial.

It's given to ensure it doesn't kill anyone or give longer term effects that will prevent it being used in the future.

It's not testing if it 'renews' the brain after a CVA - what, you think Nyrada has a whole team wandering Melbourne waiting for someone to have a stroke and give a completely untested drug within 45 minutes of injury?

Seriously?

This trial - and it hasn't even been registered with the medical ethics board (yes, you have to register) is purely to see if it is harmful to healthy humans.

That's all.

And healthy at administration, 1 week, 1 month 3 months 6 months and 12 months.

Takes a damn year to get clearance.

Show me anywhere outside of promotional company bump that this trial is going ahead this year. Just the ad requesting paid volunteers will do.

Anything.

A human trial testing the drug to see if it works post CVA takes years to set up and costs tens of millions of $$$

I hope to goodness people don't believe the things you post because they are completely wrong.

PS: Who said they were going broke? I said the SP will drift back down to 2c - and it will, as the only thing of note is a 16 mice trial.

The share price has nothing to do with how much $$ you have in the bank.

If you are sitting on profit, take it and run. You've already seen it drop from 11c to 7c.

Expand

please save me the trolling. What are you smoking

AGN took 3 months after phase 1 to receive ethical approval and submission for phase 2 for traumatic brain injury and stroke. Which is why phase 2 begins in April to May next year based on timeline

Again mate your years and years you talk about is a bunch of crock

Yeh I should sell on 10 million dollars in cash and market cap 10 million, CEO and directors all coming in more at 8 cents, backed up by us army and AGN which is a comparable company trading at a 100 million market cap pre clinical even before phase 1 trials.

You’re a troll and your explanation should be deleted for mis information. 10 years until they get clearance to dose a human the dumbest trolling I’ve seen. Phase 1 is in human trials and yes they also asses the drug is moving across the blood brain barrier and doing its job correctly

Any biotech with this potential and 10 million dollars worth of funding with a runway straight towards phase 2 being funded by the Us army after Walter reed is worth a 70-100 million market cap right now

Last edited by Roch2077: 10/05/24

NYR Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply